# Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer

> **NCT00526461** · PHASE1 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 17 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** HPPH

## Key facts

- **NCT ID:** NCT00526461
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2013-06
- **Final completion:** 2014-04
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00526461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00526461, "Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00526461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*